• Science & Technology

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer. Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.

28 February 2017

• Science & Technology

Watching how ‘young’ cells move gives clues on skin cancer spread

A new early stage study sheds some light on how a molecule helps 'young' skin cells move, which could tell us more about skin cancer. A new early stage study sheds some light on how a molecule helps 'young' skin cells move, which could tell us more about skin cancer.

23 February 2017

• Health & Medicine

World Cancer Day 2017: there are 2 types of oesophageal cancer, and they affect the world in different ways

We explore how oesophageal cancer affects different areas of the world and look at the reasons behind climbing rates of this disease. We explore how oesophageal cancer affects different areas of the world and look at the reasons behind climbing rates of this disease.

15 February 2017

• Science & Technology

Gene editing stem cells with CRISPR could help understand brain tumours

For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better. For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better.

14 February 2017

• Science & Technology
• Health & Medicine

3 of the toughest questions in cancer and more than £70 million to solve them

We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge

10 February 2017

• Science & Technology
• Charity News

Cancer Research UK announces inaugural Grand Challenge teams to answer the biggest questions in cancer

Cancer Research UK announces that four international teams are the first recipients of its global Grand Challenge competition. Cancer Research UK announces that four international teams are the first recipients of its global Grand Challenge competition.

10 February 2017

• Health & Medicine

‘Magic’ blood test could make bone marrow transplants for blood cancer safer

A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study. A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study.

9 February 2017

• Science & Technology

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic. Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

7 February 2017

• Health & Medicine

World Cancer Day 2017: global lung cancer rates reveal tobacco’s dark shadow is looming

In the first of our 4-part series for this year’s World Cancer Day we take a look at lung cancer rates in different parts of the world. In the first of our 4-part series for this year’s World Cancer Day we take a look at lung cancer rates in different parts of the world.

6 February 2017

• Science & Technology

The biology of cancer cell shape and why it’s important

Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer. Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.

1 February 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017